Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.
<h4>Introduction</h4>Active pharmacovigilance studies are pivotal to better characterize vaccine safety.<h4>Methods</h4>These are multicenter prospective cohort studies to evaluate the safety of the 2017 and 2018 seasonal trivalent influenza vaccines (TIVs) manufactured by In...
Main Authors: | Tazio Vanni, Beatriz da Costa Thomé, Mayra Martho Moura de Oliveira, Vera Lúcia Gattás, Maria da Graça Salomão, Marcelo Eiji Koike, Maria Beatriz Bastos Lucchesi, Patrícia Emília Braga, Roberta de Oliveira Piorelli, Juliana Yukari Koidara Viscondi, Gabriella Mondini, Anderson da Silva, Heloísa Maximo Espínola, Joane do Prado Santos, Samanta Hosokawa Dias de Nóvoa Rocha, Lily Yin Weckx, Olga Menang, Muriel Soquet, Alexander Roberto Precioso |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0246540 |
Similar Items
-
Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017
by: Vera Lúcia Gattás, et al.
Published: (2018-12-01) -
Perfil de segurança dos soros heterólogos produzidos pelo Instituto Butantan, São Paulo-SP, no período de 2012 a 2015
by: Vera Lúcia Gattás, et al. -
The Butantan Institute: history and future perspectives.
by: Marcelo De Franco, et al.
Published: (2014-07-01) -
Preservação do patrimônio arquitetônico no Instituto Butantan
by: Sá, Anderson Luiz Félix de
Published: (2019) -
Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan
by: Gabriella Mondini, et al.
Published: (2018-07-01)